FDA Approved: DAPAGLIFLOZIN — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approves the generic dapagliflozin from Macleods Pharmaceuticals Limited under an Original Abbreviated New Drug Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

ORIG AP for DAPAGLIFLOZIN (DAPAGLIFLOZIN)